rs148298842

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_006267.5(RANBP2):​c.2084A>C​(p.Glu695Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000767 in 1,611,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00056 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00079 ( 0 hom. )

Consequence

RANBP2
NM_006267.5 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 5.26

Publications

0 publications found
Variant links:
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07865384).
BP6
Variant 2-108753853-A-C is Benign according to our data. Variant chr2-108753853-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 469435.
BS2
High AC in GnomAd4 at 85 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANBP2NM_006267.5 linkc.2084A>C p.Glu695Ala missense_variant Exon 15 of 29 ENST00000283195.11 NP_006258.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANBP2ENST00000283195.11 linkc.2084A>C p.Glu695Ala missense_variant Exon 15 of 29 1 NM_006267.5 ENSP00000283195.6
RANBP2ENST00000697737.1 linkc.2084A>C p.Glu695Ala missense_variant Exon 15 of 27 ENSP00000513426.1
RANBP2ENST00000697740.1 linkc.2006A>C p.Glu669Ala missense_variant Exon 15 of 27 ENSP00000513427.1

Frequencies

GnomAD3 genomes
AF:
0.000558
AC:
85
AN:
152236
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00104
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000284
AC:
71
AN:
250132
AF XY:
0.000280
show subpopulations
Gnomad AFR exome
AF:
0.000318
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000460
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000789
AC:
1151
AN:
1459612
Hom.:
0
Cov.:
34
AF XY:
0.000755
AC XY:
548
AN XY:
726108
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000210
AC:
7
AN:
33406
American (AMR)
AF:
0.000112
AC:
5
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39682
South Asian (SAS)
AF:
0.000279
AC:
24
AN:
86162
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.000959
AC:
1066
AN:
1111758
Other (OTH)
AF:
0.000615
AC:
37
AN:
60206
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.340
Heterozygous variant carriers
0
78
157
235
314
392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000558
AC:
85
AN:
152236
Hom.:
0
Cov.:
31
AF XY:
0.000551
AC XY:
41
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41466
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00104
AC:
71
AN:
68046
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000753
Hom.:
0
Bravo
AF:
0.000495
ExAC
AF:
0.000404
AC:
49
EpiCase
AF:
0.00120
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Jun 18, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2084A>C (p.E695A) alteration is located in exon 15 (coding exon 15) of the RANBP2 gene. This alteration results from a A to C substitution at nucleotide position 2084, causing the glutamic acid (E) at amino acid position 695 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial acute necrotizing encephalopathy Benign:1
Sep 19, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.51
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.71
D
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.021
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.64
T
M_CAP
Benign
0.0061
T
MetaRNN
Benign
0.079
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.3
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.086
Sift
Benign
0.24
T
Sift4G
Uncertain
0.021
D
Polyphen
0.43
B
Vest4
0.25
MVP
0.36
MPC
1.1
ClinPred
0.032
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.083
gMVP
0.32
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148298842; hg19: chr2-109370309; COSMIC: COSV51701771; COSMIC: COSV51701771; API